Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome
Condition:   Nephrotic Syndrome Intervention:   Drug: ADX-629 Sponsor:   Aldeyra Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2022 Category: Research Source Type: clinical trials

Part 1 - A Clinical Trial in Children and Adults With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome
Condition:   Nephrotic Syndrome Intervention:   Drug: ADX-629 Sponsor:   Aldeyra Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2022 Category: Research Source Type: clinical trials

Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome
Condition:   Nephrotic Syndrome Intervention:   Drug: ADX-629 Sponsor:   Aldeyra Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2022 Category: Research Source Type: clinical trials